公开(公告)号：US20170266134A1

公开(公告)日：2017-09-21

申请号：US15310351

申请日：2015-05-12

Applicant: SUNOVION PHARMACEUTICALS INC.

Inventor： Antony D. LOEBEL ,  Kenneth S. KOBLAN

IPC: A61K31/135 ,  A61K9/00

CPC classification number: A61K31/135 ,  A61K9/0053 ,  A61K9/4858

Abstract: Dosage forms and treatment regimens employing dasotraline for treating Attention Deficit Hyperactivity Disorder (ADHD) are disclosed. The compositions described herein exhibit no abuse potential.

公开(公告)号：US20170266133A1

公开(公告)日：2017-09-21

申请号：US15310344

申请日：2015-05-12

Applicant: SUNOVION PHARMACEUTICALS INC.

Inventor： Antony D. LOEBEL ,  Kenneth S. KOBLAN

IPC: A61K31/135 ,  A61K9/00

CPC classification number: A61K31/135 ,  A61K9/0053 ,  A61K9/4858 ,  A61K31/136

Abstract: Dosage forms and treatment regimens employing dasotraline for treating Attention Deficit Hyperactivity Disorder (ADHD) are disclosed. The compositions described herein exhibit no abuse potential.